Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 13, 2012
[Prophylactic antibiotics and intrauterine procedures]R Shojai, A Ohannessian, J Maruani, et al.
L'Encephale|April 10, 2026
Dreams and nightmares: Clinical aspects, management, and links to psychiatric disordersJ Maruani, E Clerici, M Ambar Akkaoui, et al.
L'Encephale|December 8, 2021
Sleep quality of medical students and relationships with academic performancesN Christodoulou, J Maruani, M-P d'Ortho, et al.
Behavioural Pharmacology|January 1, 1996
Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716AA. Pério, M. Rinaldi-Carmona, J. Maruani, et al.
Psychopharmacology|July 1, 1997
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptorsM Arnone, J Maruani, F Chaperon, et al.
L'Encephale|October 18, 2022
Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohortP A Geoffroy, C M Schroder, P Bourgin, et al.
Arzneimittel-Forschung|January 1, 1984
Anticonvulsant activity of 4,9-dioxo-5,10-diazatetradecane (CM 40142), a new GABA derivative, in mice and photosensitive baboons)J P Chambon, J C Molimard, R Calassi, et al.
FEBS Letters|August 22, 1994
SR141716A, a potent and selective antagonist of the brain cannabinoid receptorM Rinaldi-Carmona, F Barth, M Héaulme, et al.
Acta Psychiatrica Scandinavica|May 31, 2018
Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remissionH Brochard, O Godin, P A Geoffroy, et al.
Neuropharmacology|February 1, 1994
Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptorsM Jung, R Calassi, J Maruani, et al.
Pageof 2